These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39297076)

  • 1. Improving clinical trial enrollment in minority racial and ethnic patients with gynecologic malignancy.
    Lara OD; Allen K; Yakubov A; Pothuri B
    Gynecol Oncol Rep; 2024 Oct; 55():101495. PubMed ID: 39297076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
    Mattei LH; Robb L; Banning K; Polan RM; Cote ML
    Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials.
    Richardson MT; Barry D; Steinberg JR; Thirunavu V; Strom DE; Holder K; Zhang N; Turner BE; Magnani CJ; Weeks BT; Young AMP; Lu CF; Wolgemuth TR; Laasiri N; Squires NA; Anderson JN; Karlan BY; Chan JK; Kapp DS; Roque DR; Salani R
    Gynecol Oncol; 2024 Feb; 181():1-7. PubMed ID: 38096673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minority Enrollment to Clinical Trials: Road to Increased Access.
    Vose J
    Oncology (Williston Park); 2021 Mar; 35(3):107. PubMed ID: 33818053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are ethnic and racial minority women less likely to participate in clinical trials?
    Patel SN; Staples JN; Garcia C; Chatfield L; Ferriss JS; Duska L
    Gynecol Oncol; 2020 May; 157(2):323-328. PubMed ID: 32253046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enrollment of Older Patients, Women, and Racial and Ethnic Minority Individuals in Valvular Heart Disease Clinical Trials: A Systematic Review.
    Reddy KP; Faggioni M; Eberly LA; Halaby R; Sanghavi M; Lewey J; Mehran R; Coylewright M; Herrmann HC; Giri J; Fanaroff AC; Nathan AS
    JAMA Cardiol; 2023 Sep; 8(9):871-878. PubMed ID: 37494015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review.
    Nouvini R; Parker PA; Malling CD; Godwin K; Costas-Muñiz R
    Cancer; 2022 Nov; 128(21):3860-3869. PubMed ID: 36107740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Distribution in Diabetic Macular Edema Clinical Trials in the United States (2002-2021).
    Yu AJ; Masalkhi M; Brown R; Chen B; Chhablani J
    Ophthalmol Retina; 2023 Dec; 7(12):1035-1041. PubMed ID: 37479084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
    Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the National Cancer Institute Community Cancer Centers Program screening and accrual log to address cancer clinical trial accrual.
    St Germain D; Denicoff AM; Dimond EP; Carrigan A; Enos RA; Gonzalez MM; Wilkinson K; Mathiason MA; Duggan B; Einolf S; McCaskill-Stevens W; Bryant DM; Thompson MA; Grubbs SS; Go RS
    J Oncol Pract; 2014 Mar; 10(2):e73-80. PubMed ID: 24424313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis.
    Ledesma Vicioso N; Lin D; Gomez DR; Yang JT; Lee NY; Rimner A; Yamada Y; Zelefsky MJ; Kalman NS; Rutter CE; Kotecha RR; Mehta MP; Panoff JE; Chuong MD; Salner AL; Ostroff JS; Diamond LC; Mathis NJ; Cahlon O; Pfister DG; Zhang Z; Chino F; Tsai J; Gillespie EF
    JCO Oncol Pract; 2022 May; 18(5):e780-e785. PubMed ID: 35544650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact and costs of targeted recruitment of minorities to the National Lung Screening Trial.
    Duda C; Mahon I; Chen MH; Snyder B; Barr R; Chiles C; Falk R; Fishman EK; Gemmel D; Goldin JG; Brown K; Munden RF; Vydareny K; Aberle DR
    Clin Trials; 2011 Apr; 8(2):214-23. PubMed ID: 21242173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    Murthy VH; Krumholz HM; Gross CP
    JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming Barriers: Evidence-Based Strategies to Increase Enrollment of Underrepresented Populations in Cancer Therapeutic Clinical Trials-a Narrative Review.
    Vuong I; Wright J; Nolan MB; Eggen A; Bailey E; Strickland R; Traynor A; Downs T
    J Cancer Educ; 2020 Oct; 35(5):841-849. PubMed ID: 31713103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities Among Participants in Precision Oncology Clinical Studies.
    Aldrighetti CM; Niemierko A; Van Allen E; Willers H; Kamran SC
    JAMA Netw Open; 2021 Nov; 4(11):e2133205. PubMed ID: 34748007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Tri-Institutional Approach to Address Disparities in Children's Oncology Group Clinical Trial Accrual for Adolescents and Young Adults and Underrepresented Minorities.
    Mittal N; Davidson J; Martinez MF; Sanchez R; Sane N; Giordano L; Choi DK; Kent P; Dighe D; Iqbal A; Kiely C; Breen K; Quigley JG; Catchatourian R; Gitelis S; Schmidt ML
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):227-235. PubMed ID: 30676208
    [No Abstract]   [Full Text] [Related]  

  • 17. Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
    Awad E; Paladugu R; Jones N; Pierce JY; Scalici J; Hamilton CA; Darcy KM; Maxwell GL; Rocconi RP
    Gynecol Oncol; 2020 Jun; 157(3):729-732. PubMed ID: 32173047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of Patients From Racial and Ethnic Minority Groups in Phase 1 Early Cancer Drug Development Trials in the US, 2000-2018.
    Dunlop H; Fitzpatrick E; Kurti K; Deeb S; Gillespie EF; Dover L; Yerramilli D; Gomez SL; Chino F; Tsai CJ
    JAMA Netw Open; 2022 Nov; 5(11):e2239884. PubMed ID: 36326764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Clinical Trial Design on Recruitment of Racial and Ethnic Minorities.
    Sheikh S; Bruno DS; Sun Y; Deng V; McClelland S; Obi E; Vinson V; Firstencel A; Lanese B; Lausin L; Dorth JA; Zaorsky NG; Hoy K; Krishnamurthi S
    J Cancer Educ; 2024 Oct; 39(5):567-572. PubMed ID: 38637443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis.
    Riaz IB; Islam M; Ikram W; Naqvi SAA; Maqsood H; Saleem Y; Riaz A; Ravi P; Wang Z; Hussain SA; Warner JL; Odedina FT; Duma N; Singh P; Kehl KL; Kamran SC; Murad MH; Landman A; Van Allen E; Bryce AH
    JAMA Oncol; 2023 Feb; 9(2):180-187. PubMed ID: 36416812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.